NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone

Back to Agenda

Session 3 : COVID-19 Vaccine Development Strategy

Associate

Korean Food & Drug Administration, Korea, Republic of

Pfizer, Australia

Director, Clinician/Global Medical Monitor

Quratis Inc., Korea, Republic of

Senior Managing Director, Head of Operations Division

Korea University Ansan Hospital , Korea, Republic of

Professor, Division of Infectious Diseases, Department of Internal Medicine

National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of

Director / Pharmacist, Ministry of Food and Drug Safety

Have an account?